
ACI Pharmaceuticals
Glucocorticoids
130 / Per Vial
Hydrocortisone is indicated for the use in the following
conditions: Primary or
secondary adrenocortical insufficiency, Acute adrenocortical insufficiency,
Shock unresponsive to conventional therapy, Congenital adrenal hyperplasia,
Hypercalcemia associated with cancer, Nonsuppurative thyroiditis, Rheumatic
Disorders, Dermatologic Diseases (Allergic States, Severe seborrheic
dermatitis, Severe psoriasis, Pemphigus, Severe erythema multiforme), Control
of severe or incapacitating allergic conditions (Bronchial asthma, Contact
dermatitis, Atopic dermatitis, Serum sickness, Seasonal or perennial allergic
rhinitis, Drug hypersensitivity reactions, Urticarial transfusion reactions,
Acute noninfectious laryngeal edema), Ophthalmic Diseases (Herpes zoster
ophthalmicus, Iritis, iridocyclitis, Chorioretinitis, Diffuse posterior uveitis
and choroiditis, Optic neuritis), Gastrointestinal Diseases, Fulminating or
disseminated pulmonary tuberculosis when used concurrently with appropriate
antituberculous chemotherapy, Loeffler's syndrome, Aspiration pneumonitis,
Hematologic Disorders (Acquired, autoimmune hemolytic anemia, Idiopathic
thrombocytopenic purpura in adults, Secondary thrombocytopenia,
Erythroblastopenia), Neoplastic Diseases (Leukemias and lymphomas in adults,
Acute leukemia of childhood), Edematous States, Acute exacerbations of multiple
sclerosis
Login To Review